PLX
Protalix BioTherapeutics, Inc.
+0.03 (+1.31%)2.72USD73.3K成交股數219M市值11.3本益比(近四季)2.7股價營收比+27.1%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 12-23 | Bashan Dror | PRESIDENT AND CEO | P 公開市場買進 | 56.0K | 1.81 | 101K | 189K | SEC |
| 2025-11-18 | 11-19 | Bar-Shalev Amos | Director | S 公開市場賣出 | 168 | 1.87 | 314.16 | 0 | SEC |
| 2025-09-03 | 09-04 | Ben Zvi Shmuel | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-09-03 | 09-04 | Elze Christian | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-09-03 | 09-04 | Bashan Dror | PRESIDENT AND CEO | A 獲配股票 | 195K | – | – | 2.3M | SEC |
| 2025-09-03 | 09-04 | Schwartz Aharon | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-09-03 | 09-04 | Melincoff Gwen A | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-09-03 | 09-04 | Naos Yaron | Sr. VP, Operations | A 獲配股票 | 25.0K | – | – | 226K | SEC |
| 2025-09-03 | 09-04 | Forster Eliot | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-09-03 | 09-04 | Bar-Shalev Amos | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-09-03 | 09-04 | Boudes Pol F | Director | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2025-06-10 | 08-12 | Schwartz Aharon | Director | P 公開市場買進 | 129K | 1.60 | 206K | 303K | SEC |
| 2024-09-23 | 11-05 | Rubin Eyal | Sr. VP and CFO | A 獲配股票 | 90.9K | – | – | 661K | SEC |
| 2024-09-23 | 09-24 | Rubin Eyal | Sr. VP and CFO | A 獲配股票 | 99.0K | – | – | 669K | SEC |
| 2024-04-01 | 04-03 | Bashan Dror | PRESIDENT AND CEO | A 獲配股票 | 264K | – | – | 2.1M | SEC |
| 2023-10-19 | 10-20 | Bashan Dror | PRESIDENT AND CEO | P 公開市場買進 | 16.1K | 1.41 | 23K | 133K | SEC |
| 2023-10-19 | 10-20 | Bashan Dror | PRESIDENT AND CEO | P 公開市場買進 | 48.4K | 1.40 | 68K | 116K | SEC |
| 2023-08-15 | 08-17 | Rubin Eyal | Sr. VP and CFO | A 獲配股票 | 202K | – | – | 570K | SEC |
| 2023-08-15 | 08-17 | Naos Yaron | Sr. VP, Operations | A 獲配股票 | 187K | – | – | 201K | SEC |
| 2023-08-15 | 08-17 | Bashan Dror | President and CEO | A 獲配股票 | 800K | – | – | 1.9M | SEC |
| 2023-08-15 | 08-17 | Hayon Yael | VP, Research & Development | A 獲配股票 | 35.1K | – | – | 35.1K | SEC |
| 2023-01-03 | 01-05 | Schwartz Aharon | Director | P 公開市場買進 | 110K | 1.42 | 156K | 174K | SEC |
| 2022-04-11 | 04-13 | Bashan Dror | President and CEO | P 公開市場買進 | 68.0K | 1.50 | 102K | 68.0K | SEC |
| 2022-02-25 | 02-28 | Rubin Eyal | Sr. VP and CFO | A 獲配股票 | 122K | – | – | 368K | SEC |
| 2022-02-25 | 02-28 | Bashan Dror | President and CEO | A 獲配股票 | 638K | – | – | 1.1M | SEC |
| 2021-06-03 | 06-03 | Dexcel Pharma Technologies Ltd. | TenPercentOwner | S 公開市場賣出 | 858K | 2.25 | 1.9M | 3.6M | SEC |
| 2021-06-03 | 06-03 | Oren Dan | TenPercentOwner | S 公開市場賣出 | 858K | 2.25 | 1.9M | 3.6M | SEC |
| 2021-06-02 | 06-03 | Dexcel Pharma Technologies Ltd. | TenPercentOwner | S 公開市場賣出 | 61.2K | 2.56 | 157K | 4.5M | SEC |
| 2021-06-02 | 06-03 | Oren Dan | TenPercentOwner | S 公開市場賣出 | 61.2K | 2.56 | 157K | 4.5M | SEC |
| 2020-08-11 | 08-14 | Rubin Eyal | Sr. VP and CFO | A 獲配股票 | 246K | – | – | 246K | SEC |
| 2020-08-11 | 08-14 | Bashan Dror | President and CEO | A 獲配股票 | 448K | – | – | 448K | SEC |
| 2020-08-11 | 08-13 | Bashan Dror | President and CEO | A 獲配股票 | 448K | – | – | 448K | SEC |
| 2020-08-11 | 08-13 | Rubin Eyal | Sr. VP and CFO | A 獲配股票 | 246K | – | – | 246K | SEC |
| 2020-04-07 | 04-13 | Schwartz Aharon | Director | P 公開市場買進 | 64.0K | 2.43 | 156K | 64.0K | SEC |
| 2017-05-16 | 05-16 | Manor Moshe | President & CEO | P 公開市場買進 | 50.0K | 0.81 | 41K | 50.0K | SEC |
| 2016-12-02 | 12-06 | Camber Capital Management LLC | TenPercentOwner | S 公開市場賣出 | 2.5M | 0.32 | 800K | 10.8M | SEC |
| 2016-09-15 | 09-16 | Shaaltiel Yoseph | Executive VP, R&D | M 選擇權執行 | 122K | – | – | 586K | SEC |
| 2015-12-14 | 12-15 | Maimon Yossi | Vice President & CFO | P 公開市場買進 | 10.0K | 0.78 | 8K | 10.0K | SEC |
| 2015-10-19 | 10-20 | Camber Capital Management LLC | TenPercentOwner | P 公開市場買進 | 423 | 1.03 | 435.69 | 13.3M | SEC |
| 2015-10-19 | 10-20 | Camber Capital Management LLC | TenPercentOwner | P 公開市場買進 | 4.0M | 1.00 | 4.0M | 13.3M | SEC |
| 2014-10-02 | 10-06 | Bronfeld Zeev | Director | J 其他 | 1.5M | – | – | 0 | SEC |
| 2014-10-02 | 10-06 | Bronfeld Zeev | Director | J 其他 | 324K | – | – | 2.2M | SEC |
| 2014-09-16 | 09-18 | Bronfeld Zeev | Director | J 其他 | 1.8M | – | – | 1.8M | SEC |
| 2014-09-16 | 09-18 | Bronfeld Zeev | Director | J 其他 | 8.6M | – | – | 1.5M | SEC |
| 2014-09-16 | 09-18 | Bio-Cell Ltd | TenPercentOwner | J 其他 | 8.6M | – | – | 1.5M | SEC |
| 2014-08-13 | 08-15 | Bio-Cell Ltd | TenPercentOwner | S 公開市場賣出 | 4.4M | 2.47 | 10.9M | 10.1M | SEC |
| 2014-08-13 | 08-15 | Bronfeld Zeev | Director,TenPercentOwner | S 公開市場賣出 | 4.4M | 2.47 | 10.9M | 10.1M | SEC |
| 2013-08-15 | 08-16 | Akirov Alfred | Director | S 公開市場賣出 | 2.3K | 5.07 | 12K | 4.9M | SEC |
| 2013-08-14 | 08-16 | Akirov Alfred | Director | S 公開市場賣出 | 5.0K | 5.07 | 25K | 4.9M | SEC |
| 2013-08-14 | 08-16 | Akirov Alfred | Director | S 公開市場賣出 | 100K | 5.05 | 505K | 4.9M | SEC |
| 2013-08-14 | 08-16 | Akirov Alfred | Director | S 公開市場賣出 | 5.0K | 5.08 | 25K | 4.9M | SEC |
| 2013-03-12 | 03-14 | Akirov Alfred | Director | S 公開市場賣出 | 10.0K | 5.70 | 57K | 5.0M | SEC |
| 2013-03-11 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 5.0K | 5.71 | 29K | 5.0M | SEC |
| 2013-03-11 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 3.0K | 5.75 | 17K | 5.1M | SEC |
| 2013-03-11 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 300 | 5.79 | 2K | 5.1M | SEC |
| 2013-03-11 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 10.0K | 5.72 | 57K | 5.0M | SEC |
| 2013-03-08 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 1.9K | 5.95 | 11K | 5.1M | SEC |
| 2013-03-08 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 2.5K | 5.91 | 15K | 5.1M | SEC |
| 2013-03-08 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 10.0K | 5.82 | 58K | 5.1M | SEC |
| 2013-03-08 | 03-12 | Akirov Alfred | Director | S 公開市場賣出 | 2.5K | 5.92 | 15K | 5.1M | SEC |
| 2013-03-07 | 03-08 | Akirov Alfred | Director | S 公開市場賣出 | 5.0K | 5.71 | 29K | 5.1M | SEC |
| 2013-03-07 | 03-08 | Akirov Alfred | Director | S 公開市場賣出 | 3.4K | 5.73 | 20K | 5.1M | SEC |
| 2013-03-06 | 03-08 | Akirov Alfred | Director | S 公開市場賣出 | 700 | 5.71 | 4K | 5.1M | SEC |
| 2013-03-06 | 03-08 | Akirov Alfred | Director | S 公開市場賣出 | 2.0K | 5.69 | 11K | 5.1M | SEC |
| 2013-03-06 | 03-08 | Akirov Alfred | Director | S 公開市場賣出 | 2.0K | 5.68 | 11K | 5.1M | SEC |
| 2012-07-16 | 07-18 | Almon Einat Brill | SVP, Product Development | A 獲配股票 | 185K | – | – | 185K | SEC |
| 2012-07-16 | 07-18 | Shaaltiel Yoseph | Executive VP, R&D | A 獲配股票 | 210K | – | – | 210K | SEC |
| 2012-07-16 | 07-18 | Aviezer David | President & CEO | A 獲配股票 | 418K | – | – | 418K | SEC |
| 2012-07-16 | 07-18 | Lauterbach Sandra Leigh | VP, Sales & Commercial Affairs | A 獲配股票 | 20.0K | – | – | 20.0K | SEC |
| 2012-07-16 | 07-18 | Palash Tzvi | Chief Operating Officer | A 獲配股票 | 102K | – | – | 102K | SEC |
| 2012-07-16 | 07-18 | Maimon Yossi | Vice President & CFO | A 獲配股票 | 185K | – | – | 185K | SEC |
| 2012-05-02 | 05-04 | Maimon Yossi | VP, Chief Financial Officer | S 公開市場賣出 | 126K | 7.13 | 898K | 0 | SEC |
| 2012-05-02 | 05-04 | Maimon Yossi | VP, Chief Financial Officer | M 選擇權執行 | 76.0K | 0.97 | 74K | 76.0K | SEC |
| 2012-05-02 | 05-04 | Aviezer David | President & CEO | S 公開市場賣出 | 450K | 7.13 | 3.2M | 0 | SEC |
| 2012-05-02 | 05-04 | Aviezer David | President & CEO | M 選擇權執行 | 124K | 0.97 | 120K | 450K | SEC |
| 2012-05-02 | 05-04 | Aviezer David | President & CEO | M 選擇權執行 | 326K | 0.12 | 39K | 326K | SEC |
| 2012-05-02 | 05-04 | Almon Einat Brill | SVP, Product Development | S 公開市場賣出 | 167K | 7.13 | 1.2M | 0 | SEC |
| 2012-05-02 | 05-04 | Maimon Yossi | VP, Chief Financial Officer | M 選擇權執行 | 50.0K | 2.65 | 133K | 126K | SEC |
| 2012-05-02 | 05-04 | Almon Einat Brill | SVP, Product Development | M 選擇權執行 | 50.0K | 2.65 | 133K | 167K | SEC |
| 2012-05-02 | 05-04 | Almon Einat Brill | SVP, Product Development | M 選擇權執行 | 117K | 0.97 | 113K | 117K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.0M | 9.4M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.1M | 2.6M | 新進 | 新進 |
| STATE STREET CORP | 984K | 2.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 980K | 2.3M | 新進 | 新進 |
| NORTHERN TRUST CORP | 922K | 2.1M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 511K | 1.2M | 新進 | 新進 |
| Stratos Wealth Partners, LTD. | 500K | 1.2M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 493K | 1.1M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 476K | 1.1M | 新進 | 新進 |
| MARSHALL WACE, LLP | 453K | 1.1M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 334K | 779K | 新進 | 新進 |
| STRS OHIO | 296K | 690K | 新進 | 新進 |
| Bank of New York Mellon Corp | 233K | 543K | 新進 | 新進 |
| Main Street Financial Solutions, LLC | 214K | 499K | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189K | 441K | 新進 | 新進 |
| Hillsdale Investment Management Inc. | 186K | 433K | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 180K | 420K | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 172K | 400K | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 168K | 391K | 新進 | 新進 |
| LAZARD ASSET MANAGEMENT LLC | 166K | 386K | 新進 | 新進 |
| UBS Group AG | 139K | 323K | 新進 | 新進 |
| JPMORGAN CHASE & CO | 133K | 313K | 新進 | 新進 |
| Nuveen, LLC | 90.2K | 210K | 新進 | 新進 |
| DEUTSCHE BANK AG\ | 77.5K | 181K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 70.3K | 164K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 102 +2 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 102 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 14.5M · 17.9% |
| 合計季末市值 | 33.5M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.2M |
|---|---|
| 與上期比 | -11.5% |
| 佔流通股數 | 3.93% |
| 日均成交量 | 666K |
| 回補天數 | 4.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.2M | -11.5% | 3.93% | 666K | 4.8 |
| 2026-08-14 | 3.6M | -7.8% | 4.44% | 964K | 3.7 |
| 2026-07-31 | 3.9M | +4.4% | 4.81% | 520K | 7.5 |
| 2026-07-15 | 3.7M | +4.4% | 4.61% | 566K | 6.6 |
| 2026-06-30 | 3.6M | -9.0% | 4.42% | 851K | 4.2 |
| 2026-06-15 | 3.9M | -0.6% | 4.85% | 553K | 7.1 |
| 2026-05-29 | 3.9M | -6.0% | 4.88% | 799K | 4.9 |
| 2026-05-15 | 4.2M | -17.2% | 5.19% | 1.1M | 3.9 |
| 2026-04-30 | 5.1M | +7.0% | 6.27% | 519K | 9.7 |
| 2026-04-15 | 4.7M | +0.5% | 5.87% | 711K | 6.7 |
| 2026-03-31 | 4.7M | +7.4% | 5.84% | 1.2M | 3.9 |
| 2026-03-13 | 4.4M | +4.9% | 5.43% | 974K | 4.5 |
| 2026-02-27 | 4.2M | -7.8% | 5.18% | 1.5M | 2.8 |
| 2026-02-13 | 4.5M | +10.0% | 5.62% | 2.2M | 2.1 |
| 2026-01-30 | 4.1M | -9.5% | 5.11% | 895K | 4.6 |
| 2026-01-15 | 4.6M | +8.0% | 5.65% | 1.0M | 4.3 |
| 2025-12-31 | 4.2M | -4.6% | 5.23% | 622K | 6.8 |
| 2025-12-15 | 4.4M | +6.2% | 5.48% | 517K | 8.6 |
| 2025-11-28 | 4.2M | +1.4% | 5.16% | 508K | 8.2 |
| 2025-11-14 | 4.1M | -1.4% | 5.09% | 626K | 6.6 |
| 2025-10-31 | 4.2M | -11.7% | 5.16% | 1.1M | 3.6 |
| 2025-10-15 | 4.7M | +13.3% | 5.84% | 1.0M | 4.6 |
| 2025-09-30 | 4.2M | +13.4% | 5.15% | 683K | 6.1 |
| 2025-09-15 | 3.7M | +1.8% | 4.54% | 824K | 4.4 |
| 2025-08-29 | 3.6M | -4.4% | 4.46% | 587K | 6.1 |
| 2025-08-15 | 3.8M | +3.6% | 4.67% | 566K | 6.7 |